ArticleScientific reports2025
Strain-specific activation of aspergillic acid biosynthesis in Aspergillus oryzae NRRL 3483.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Aspergillic acid, a hydroxamate-containing pyrazinone derived from leucine and isoleucine, is a hallmark metabolite of Aspergillus flavus, which also produces the potent carcinogen aflatoxin. Its biosynthesis is governed by the recently characterized asa gene cluster. While A. flavus consistently produces aspergillic acid, its domesticated relative Aspergillus oryzae has long been considered a non-producer. Here, we compared the asa cluster activity and metabolite output in A. flavus NRRL 3357 and two A. oryzae strains (RIB40 and NRRL 3483) under amino acid-rich conditions. In A. flavus, asa genes were strongly induced in casein peptone medium, resulting in robust production of aspergillic acid, deoxyaspergillic acid, and iron-chelating ferriaspergillin. A. oryzae RIB40 showed no transcriptional activation or metabolite production. By contrast, A. oryzae NRRL 3483 exhibited clear asa cluster induction and detectable accumulation of deoxyaspergillic acid and trace aspergillic acid sufficient to form ferriaspergillin. Notably, the disproportionate buildup of deoxyaspergillic acid revealed a bottleneck in downstream tailoring steps. These results demonstrate that A. oryzae retains strain-specific, conditionally inducible aspergillic acid biosynthesis, highlighting evolutionary attenuation of secondary metabolism in domesticated fungi. This work establishes a framework for dissecting regulatory and enzymatic constraints in the asa pathway, highlighting the potential of hidden biosynthetic clusters for natural product discovery and biotechnological applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.